APA (7th ed.) Citation

A, A., E, E., C, V., S, P., N, S., M, R., . . . S, R. (2026). Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy. Bone marrow transplantation, 61(6), 685. https://doi.org/10.1038/s41409-026-02838-9

Chicago Style (17th ed.) Citation

A, Alonso-Saladrigues, et al. "Impact of TP53 Alterations on Outcomes in Pediatric and Young Adult Patients with Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia After CD19-CAR T-Cell Therapy." Bone Marrow Transplantation 61, no. 6 (2026): 685. https://doi.org/10.1038/s41409-026-02838-9.

MLA (9th ed.) Citation

A, Alonso-Saladrigues, et al. "Impact of TP53 Alterations on Outcomes in Pediatric and Young Adult Patients with Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia After CD19-CAR T-Cell Therapy." Bone Marrow Transplantation, vol. 61, no. 6, 2026, p. 685, https://doi.org/10.1038/s41409-026-02838-9.